We are thrilled to share why we are so excited about the four finalists for the 2022-2023 F.M. KirbyImpact Prize. Check the CASE blog for posts on the other finalists. The Problem Kidogo is Working to Solve Kidogo is helping …
We are thrilled to share why we are so excited about each of the four finalists for the 2022-2023 F.M. Kirby Impact Prize. Check the CASE blog for posts about the other finalists. The Problem Hello World is Working to Solve Hello World …
From a pool of 180, four social enterprises stood out above the rest in this year’s competition for the Fred Morgan Kirby Prize for Scaling Social Impact, which CASE has the privilege to manage. One of these four will ultimately be …
Summer internships are a valuable time for MBAs to explore and validate their interests. The Fuqua Summer Internship Fund (SIF) enables students to learn about the rewards and challenges of social impact management without making a significant financial sacrifice – and enables …
This year CASE celebrated our 20th anniversary, and the 10th anniversary of the CASE i3 Initiative on Impact Investing. This anniversary allowed us to reflect on how our work has evolved over the years to meet the needs to today’s …
The social problems that we face as a global community are urgent and we need leaders with the skills, courage, and support to drive for a more just, equitable, and sustainable world. This is why CASE was thrilled to partner …
Each year, CASE selects a group of Fuqua MBAs to serve as CASE and CASE i3 Fellows. These students have stood out to us in their passion and commitment to taking a deeper dive into their social impact or impact investing learning with …
CASE is excited to bring on a new member to our hard-working and high impact team. Highlights of the position are below. Know a great candidate? Please share the full job description found here. Send questions about this position to …
Eighty nine million Americans avoid buying at least one of the top-9 allergen food products. Of these 89 million, 25 million have a severe or moderate allergy, 7 million have a mild allergy, 32 million have food intolerances. Twenty-five million …
Get right what so many organizations get wrong about scale. How can you ensure that you don’t waste your time pursuing a weak scaling strategy that’s unlikely to be funded? How can you demonstrate to internal stakeholders and funders that …
